comprehensive -WSS

comprehensive

author：comprehensive 2025-09-28 02:26:49 - browse：7644

light shines behind Pfizer CEO Albert Bourla as he attends a ceremony in Greece — Pfizer CEO Albert Bourla Giannis Papanikos/AP

Pfizer has a big problem. The drug giant hopes that new drugs to treat cancer are the solution.

Shares in the drugmaker fell 44% last year, and it now has a market capitalization of only $150 billion — a quarter that of Eli Lilly and half that of longtime rival Merck. In March of last year the company announced that it would spend $43 billion to buy Seagen, a maker of a hot category of oncology medicines called antibody-drug conjugates. Pfizer’s shares have slumped another 9% so far this year. On Thursday, executives are holding an investor briefing to try to convince shareholders that its bet will pay off.

In an interview with STAT, Pfizer CEO Albert Bourla was insistent that the deal’s potential is being missed.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Lawmakers grill UnitedHealth CEO on Change cyberattack

explore

WSS

HHS's proposed rule does nothing to address the climate crisis

Alabama IVF ruling threatens families facing fatal genetic disease

Alabama IVF ruling threatens families facing fatal genetic disease

Lawmakers grill UnitedHealth CEO on Change cyberattack

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

Novel spinal cord stimulator treats paralysis without surgery

hotspot

comprehensive

explore

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

PBM executives asked to testify by House panel

Tori Bowie and the unacceptable rates of Black maternal death

Community Health Systems hospitals under DOJ investigation

Novavax promises a turnaround & Lilly roils the obesity market

Chemotherapy before breast cancer surgery might fuel metastasis

State Dept. review finds Biden bears some blame for Afghanistan failures

AI for drug discovery: Experts on separating hype from reality

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Brain technologies pose threats that are all too real, experts warn

hotspot

PBM reform efforts get punted in Congress

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

Warren pushes Witty on UnitedHealth's control over physicians

In utero gene editing: an explainer

Can gargling with Listerine treat gonorrhea of the mouth?

In utero gene editing: an explainer

hotspot

explore

explore

hotspot